Efficacy and safety of semaglutide according to frailty status

Efficacy and safety of integrative and complementary treatments versus conventional therapies in patients with vitiligo: A systematic review

New method enables AI for safety-critical situations

Novel dual-target IL-17A/F monoclonal antibody XKH004 shows 52-week efficacy and safety in active ankylosing spondylitis in phase 3 trial